logo
  • About Initiator Pharma
    • Mission
    • Scientific and Clinical Advisory Board
    • Goals, strategy and business model
    • CEO Letter
    • History
  • Science
    • Pipeline
      • Pudafensine Clinical Program
      • IP2018 Clinical Program
      • IPTN2021 Clinical Program
      • IP2017 Program* (preclinical)
      • IP2016 Program* (preclinical)
    • Technology & Therapeutic Areas
      • Erectile Dysfunction
      • Depression
      • Trigeminal Neuralgia
  • Governance
    • General Meetings
    • Management
    • Board of Directors
    • Auditing
    • Articles of Association
    • Remuneration and incentive program
  • Investors
    • Investment case
    • Reports and Presentations
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser
  • Media
    • Press Releases
    • Event Calendar
    • Subscribe
  • Contact
Loading..

Financial Calendar

All years
  • Upcoming events
  • 2024
  • 2023
  • 2022
  • 2021
  • All years
Financial calendar
  • Event calendar
  • All events
February 19, 2021

Year-end report 2020 (Q4)

Add to calendar
May 25, 2021

Interim Q1 2021 report

Add to calendar
May 28, 2021

Annual General Meeting

Add to calendar
August 20, 2021

Interim report 1st half 2021

Add to calendar
November 19, 2021

Interim Q3 2021 report

Add to calendar
February 18, 2022

Year-end report 2021 (Q4)

Add to calendar
April 27, 2022

Annual Report 2021

Add to calendar
May 6, 2022

Interim Q1 2022 report

Add to calendar
May 24, 2022

Annual General Meeting 2022

Add to calendar
August 26, 2022

Interim report 1st half 2022

Add to calendar
November 4, 2022

Interim Q3 2022 report

Add to calendar
February 17, 2023

Year-end report 2022 (Q4)

Add to calendar
May 2, 2023

Annual Report 2022

Add to calendar
May 5, 2023

Interim Q1 2023 report

Add to calendar
May 26, 2023

Annual General Meeting 2023

Add to calendar
August 25, 2023

Interim report 1st half 2023

Add to calendar
November 10, 2023

Interim Q3 2023 report

Add to calendar
February 23, 2024

Year-end report 2023 (Q4)

Add to calendar
  • Investors
    • Investment case
    • Reports and Presentations
    • The Share
    • Ownership Structure
    • Analyst and Media Coverage
    • Financial Calendar
    • Prospectuses
    • Press Releases
    • Subscribe
    • Certified Adviser

Share

Read more
Initiator Pharma logo
About Initiator Pharma
  • Mission
  • Scientific and Clinical Advisory Board
  • Goals, strategy and business model
  • CEO Letter
  • History
Science
  • Pipeline
    • Pudafensine Clinical Program
    • IP2018 Clinical Program
    • IPTN2021 Clinical Program
    • IP2017 Program* (preclinical)
    • IP2016 Program* (preclinical)
  • Technology & Therapeutic Areas
    • Erectile Dysfunction
    • Depression
    • Trigeminal Neuralgia
Governance
  • General Meetings
  • Management
  • Board of Directors
  • Auditing
  • Articles of Association
  • Remuneration and incentive program
Investors
  • Investment case
  • Reports and Presentations
  • The Share
  • Ownership Structure
  • Analyst and Media Coverage
  • Financial Calendar
  • Prospectuses
  • Press Releases
  • Subscribe
  • Certified Adviser
Media
  • Press Releases
  • Event Calendar
  • Subscribe
Contact

Share

Read more
  • Cookies
  • Privacy